TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CTOR

Citius Oncology, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

1.10$ +11.8% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Citius Oncology, Inc. (CTOR): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/11/2026.

Next report 08/11/2026
Last report 08/14/2026
Earnings surprise by quarter (%)
Q3 24 · -282.4 % 24 Q4 24 · -55.2 % 24 Q1 25 · -22.2 % 25 Q2 25 · 46.7 % 25 Q3 25 · 0.0 % 25 Q4 25 · -200.0 % 25 Q1 26 · -2,600.0 % 26 Q2 26 · -14.3 % 26

EPS estimate beaten

Full history 1 of 8 quarters (13%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/14/2026 CITIUS ONCOLOGY, INC. (CTOR): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/12/2026 CITIUS ONCOLOGY, INC. (CTOR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/05/2026 CITIUS ONCOLOGY, INC. (CTOR): Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?